Legal
Legal disclaimer.
Important information about the use of vectorgene.hk, the regulatory status of advanced therapy programmes and the limits of the information on this website.
Effective date: 26 October 2026 · Last updated: 26 October 2026
01 · Purpose of this website
vectorgene.hk is operated by VectorGene Biotech Limited, a company incorporated in Hong Kong (company registration no. 77684304) with its registered office at Tower 1, 2/F, Tern Centre, 237 Queen’s Road Central, Sheung Wan, Hong Kong Island, Hong Kong (“VectorGene”, “we”, “us” or “our”).
This website is intended for institutional and professional audiences, including governments, public health authorities, hospitals, research institutes, biotechnology and pharmaceutical companies, investors and patient organisations.
The information on vectorgene.hk is provided for institutional and partnership-discussion purposes only. It is not intended for, and should not be relied on by, individual patients or members of the public seeking personal medical guidance.
02 · Not medical advice
Information on this website does not constitute medical advice, diagnosis, treatment recommendation or clinical guidance. It is not a substitute for consultation with a qualified healthcare professional and should not be used as the basis for any medical decision.
Patients, families and individuals seeking medical guidance should consult their treating physician or a qualified healthcare provider. VectorGene does not provide direct patient care, treatment delivery or clinical recommendations through this website.
References to diseases, treatment indications, clinical workflows or therapeutic platforms are descriptive only. They inform institutional partners about the scope of VectorGene’s technology transfer and partnership activities.
03 · Advanced therapy regulatory status
VectorGene supports technology transfer programmes across genomics, CAR-T manufacturing, advanced cell therapy and gene therapy. The regulatory status of any therapy depends on the product, the indication, the protocol and the country in which it is used. Every platform and service on this website must be read with its regulatory note.
Readers should not assume that:
- Any therapy described on this website is approved, registered or commercially available in their country.
- Any clinical claim, indication or outcome applies to a particular patient or context.
- A therapy referenced on this website has received marketing authorisation or regulatory clearance in any specific jurisdiction.
Cell and gene therapy programmes may be approved, investigational, in clinical trials or under early-access pathways, depending on the country, indication, protocol and regulatory status. Any clinical use requires institutional review, regulatory approval, physician assessment, patient eligibility review, informed consent and long-term safety monitoring as required by the host country’s regulatory framework.
VectorGene does not represent or warrant that any therapy described on this website is safe, effective or appropriate for any specific individual or condition.
04 · Technology transfer is conditional
Descriptions of VectorGene’s technology transfer services describe capabilities and intended programmes. Delivery of any specific technology transfer is always subject to:
- A signed partnership agreement, memorandum of understanding or service contract between VectorGene and the partner institution.
- A successful feasibility assessment, including regulatory, infrastructure and clinical readiness review.
- Local regulatory approvals, including ethics committee clearance, regulatory authority authorisation and any applicable import or technology transfer permissions.
- Compliance with applicable export control laws and international technology transfer regulations.
- Availability of the technology source from VectorGene’s partner network at the time of engagement.
Nothing on this website is a guarantee that a specific technology transfer will be available, successful or commercially viable in any country or institutional context.
05 · No commercial offer
The information on vectorgene.hk is not an offer to sell, license or transfer any product, service, technology, intellectual property or security in any jurisdiction. It is not a solicitation of an offer and it is not a binding commercial proposal. Website descriptions and typical timelines are discussion material, not a quotation.
Any commercial engagement with VectorGene is governed exclusively by the terms of a separately negotiated and executed written agreement.
06 · Forward-looking statements
This website may contain forward-looking statements about VectorGene’s intended programmes, partnerships, technology platforms, geographic expansion or commercial development. They are based on current expectations and assumptions and are subject to risks and uncertainties.
Actual results may differ materially because of factors including regulatory changes, partner availability, clinical and scientific developments, geopolitical conditions and commercial circumstances. VectorGene undertakes no obligation to update forward-looking statements except as required by applicable law.
07 · Third-party content
This website may refer to third-party institutions, partners, technologies or external resources for informational and partnership-discussion purposes. A reference to a third party does not imply endorsement, sponsorship or affiliation unless explicitly stated.
CHGB service scope and quantitative figures are partner-reported. Programme-specific supporting evidence and validation information should be requested during feasibility.
VectorGene is not responsible for the content, accuracy or practices of any third-party website or institution linked from or referred to on this website. Public references to specific partner institutions are made only where VectorGene has appropriate authorisation to do so.
08 · Intellectual property
All content on vectorgene.hk, including text, layout, design, graphics, logos, icons, images and underlying code, is the property of VectorGene Biotech Limited or its licensors and is protected by applicable intellectual property laws.
You may view and use the website for legitimate institutional and informational purposes. Without prior written permission from VectorGene, you may not:
- Reproduce, republish or redistribute substantial portions of the website content.
- Use the content for commercial purposes other than evaluating a possible partnership with VectorGene.
- Modify, adapt or create derivative works based on the website content.
- Remove or alter any copyright, trademark or proprietary notices.
Technology, methods, workflows and know-how described on this website that belong to VectorGene’s partner institutions remain the intellectual property of those partners and are subject to their licensing terms. No rights are granted by viewing this website.
09 · Trademarks
“VectorGene”, the VectorGene logo and related visual identity elements are trademarks or unregistered marks of VectorGene Biotech Limited. Third-party trademarks, product names and institution names referred to on this website belong to their respective owners. Reference to them does not imply endorsement or affiliation unless explicitly stated.
10 · Limitation of liability
To the fullest extent permitted by applicable law:
- The information on vectorgene.hk is provided “as is”, without warranties of any kind, whether express or implied, including warranties of accuracy, completeness, merchantability, fitness for a particular purpose or non-infringement.
- VectorGene does not warrant that the website will be uninterrupted, secure or free from errors or technical issues.
- VectorGene is not liable for any direct, indirect, incidental, consequential, special, exemplary or punitive damages arising from or related to the use of, or inability to use, this website, including loss of profits, data, business, opportunity or reputation.
Nothing in this disclaimer excludes or limits liability that cannot be excluded under Hong Kong law.
11 · Indemnification
You agree to indemnify and hold harmless VectorGene Biotech Limited, its directors, officers, employees and partners from and against any claims, damages, losses, liabilities and expenses (including reasonable legal fees) arising out of or related to:
- Your misuse of this website or its content.
- Your violation of this legal disclaimer or any applicable law.
- Reliance on website content for medical, regulatory, commercial or investment decisions in a way that is inconsistent with the limitations in this disclaimer.
12 · Governing law & jurisdiction
This legal disclaimer and your use of vectorgene.hk are governed by the laws of the Hong Kong Special Administrative Region of the People’s Republic of China, without regard to its conflict-of-law principles.
Any dispute, claim or controversy arising out of or relating to this disclaimer or the use of this website is subject to the exclusive jurisdiction of the courts of Hong Kong, except where mandatory consumer protection laws of another jurisdiction apply.
13 · Updates & contact
VectorGene may update this legal disclaimer at any time. Changes take effect on the date of posting, and the “Last updated” date at the top of this page shows the most recent revision. Continued use of the website after a change means you accept the revised disclaimer.
For questions about this legal disclaimer, contact us using the details below.
VectorGene Biotech Limited
Registered office: Tower 1, 2/F, Tern Centre, 237 Queen’s Road Central, Sheung Wan, Hong Kong Island, Hong Kong
Company registration no. 77684304
Beijing: 16-3008, Building 16, Jianwai SOHO West Zone, Chaoyang District, Beijing 100022, China
Kolkata: A4C, Sherwood Estate, Narendrapur, Kolkata 700103, India
Working environments
Clear scope. Documented responsibilities.
Illustrative stock photography provides context for the people, processes and working environments behind this capability.





